CLEVELAND, OH, Neuronoff, a clinical-stage medical device company, announced the closure of an oversubscribed $4.5 million financing round.
Neuronoff, a clinical-stage medical device company pioneering minimally invasive pain treatments, announced the closure of an oversubscribed $4.5 million financing round to advance its Injectrode platform toward FDA clearance and commercial launch.
(c) by Massinvestor, Inc. For contact info, please check out our
about page.
